Skip to main content

Table 2 Longitudinal study patient demographics

From: Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study

 

AECOM cohort

OSS cohort

Pvalue

Number of patients (% female)

31 (81)

13 (100)

0.091

Lupus nephritis (%)

58

100

0.005*

Number of visits per patient

3 (2 to 5)

3 (2 to 5)

0.508

Time between visits (months)

3 (2 to 6)

2 (2 to 6)

 

Ethnicitya

18/12/0/1

5/0/8/0

 

African American (%)

58

38

0.235

Age at first visit (years)

36 (31 to 44)

30 (28 to 36)

0.089

rSLEDAIb

4 (0 to 8)

4 (0 to 4)

 

World Health Organization classb, n (%)

   

   III

6 (33)

1 (8)

0.092

   IV

9 (50)

9 (69)

0.284

   V

2 (11)

3 (23)

0.371

   VI

1 (6)

0 (0)

0.388

Serum creatinine levels

0.8 (0.7 to 1.0)

1.0 (0.8 to 1.6)

 

   Only lupus nephritis patients

0.9 (0.7 to 1.1)

  

   At first visitb

0.8 (0.7 to 1.2)

1.03 (0.8 to 1.5)

0.160

  1. Continuous variables presented as the median (interquartile range). AECOM, Albert Einstein College of Medicine; OSS, Ohio SLE Study; rSLEDAI, renal Systemic Lupus Erythematosus Disease Activity Index. aAfrican American/Hispanic/Caucasian/other.bLupus nephritis patients only. *P < 0.05. Continuous variables were compared by the Mann- Whitney U test, while the two-sample proportion test was used for categorical variables. Statistical comparisons were not performed when values were not independent of each other.